European Respiratory Review

Papers
(The TQCC of European Respiratory Review is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
The respiratory microbiome and nontuberculous mycobacteria: an emerging concern in human health197
Interventions for the management of malignant pleural effusions: an updated network meta-analysis161
The measurement properties of tests and tools used in cystic fibrosis studies: a systematic review159
The application of barium oesophagography in patients with suspected tracheo-oesophageal fistula: preferred or avoided?153
The role of telemonitoring in patients on home mechanical ventilation102
Non-typeableHaemophilus influenzaeairways infection: the next treatable trait in asthma?97
European Respiratory Review, list of peer reviewers 202291
Phage therapy for pulmonary infections: lessons from clinical experiences and key considerations85
Selection of potential targets for stratifying congenital pulmonary airway malformation patients with molecular imaging: is MUC1 the one?82
A critical interpretive synthesis of the lived experiences and health and patient-reported outcomes of people living with COPD who isolated during the COVID-19 pandemic82
Association of preserved ratio impaired spirometry with mortality: a systematic review and meta-analysis66
Metabolomics and microbiome profiling as biomarkers in obstructive sleep apnoea: a comprehensive review65
Training in interventional pulmonology: the European and US perspective63
Prevalence, risk factors and treatments for post-COVID-19 breathlessness: a systematic review and meta-analysis62
Reply to: “Nicotine or tobacco abstinence?”60
ERS/EAACI statement on adherence to international adult asthma guidelines59
Liposomal drug delivery to manage nontuberculous mycobacterial pulmonary disease and other chronic lung infections56
Cardiopulmonary exercise testing in interstitial lung diseases and the value of ventilatory efficiency55
Parasitic lung diseases54
Molecular monitoring of lung allograft health: is it ready for routine clinical use?52
Positive airway pressure therapy for post-stroke sleep disordered breathing: a systematic review, meta-analysis and meta-regression51
The world of rare interstitial lung diseases50
New trends in pulmonary hypertension49
Lost in translation: a neglected mTOR target for lymphangioleiomyomatosis46
Cough symptom severity in patients with refractory or unexplained chronic cough: a systematic survey and conceptual framework45
Medication adherence to CFTR modulators in patients with cystic fibrosis: a systematic review43
Preclinical models of maternal asthma and progeny outcomes: a scoping review43
Natural killer cells in the lung: potential role in asthma and virus-induced exacerbation?42
Ventilatory efficiency and its clinical and prognostic value in adults with cystic fibrosis42
Peripheral blood monocyte count and outcomes in patients with interstitial lung disease: a systematic review and meta-analysis41
Ergonomics of bronchoscopy: good advice or a pain in the neck?40
The ventilatory efficiency and its clinical and prognostic value in cardiorespiratory disorders39
Resectable non-stage IV nonsmall cell lung cancer: the surgical perspective39
Perioperative approach to precapillary pulmonary hypertension in non-cardiac non-obstetric surgery38
Exacerbations of bronchiectasis38
The efficacy of immune checkpoint inhibitors in thoracic malignancies37
Eosinophils and eosinophilic immune dysfunction in health and disease37
Opioids for the palliation of symptoms in people with serious respiratory illness: a systematic review and meta-analysis36
Ventilation/perfusion mismatch is not the sole reason for hypoxaemia in early stage COVID-19 patients35
Exploring the 175-year history of spirometry and the vital lessons it can teach us today35
Interstitial pneumonia with autoimmune features: challenges and controversies34
Polyphenols, flavonoids and inflammasomes: the role of cigarette smoke in COPD34
Smouldering fire or conflagration? An illustrated update on the concept of inflammation in pulmonary arterial hypertension34
Growing from common ground: nontuberculous mycobacteria and bronchiectasis33
Predicting the pulmonary effects of long-term e-cigarette use: are the clouds clearing?33
European Respiratory Review, list of peer reviewers 202133
European Respiratory Review, list of peer reviewers 202332
Does pulmonary rehabilitation address treatable traits? A systematic review32
Unravelling the mechanisms driving multimorbidity in COPD to develop holistic approaches to patient-centred care31
The epithelial era of asthma research: knowledge gaps and future direction for patient care31
Association between second-hand smoke exposure and lung cancer risk in never-smokers: a systematic review and meta-analysis31
Occupation and SARS-CoV-2 in Europe: a review31
Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis30
Deep learning for pneumothorax diagnosis: a systematic review and meta-analysis30
Multicomponent services for symptoms in serious respiratory illness: a systematic review and meta-analysis30
Chronic lung diseases: entangled in extracellular matrix29
Asthma-COPD overlap: current understanding and the utility of experimental models29
Post-acute COVID-19 syndrome29
Management ofMycobacterium aviumcomplex andMycobacterium abscessuspulmonary disease: therapeutic advances and emerging treatments28
Lung transplantation for interstitial lung disease28
Burden of respiratory syncytial virus infection in older and high-risk adults: a systematic review and meta-analysis of the evidence from developed countries28
“Exercise intolerance in pulmonary arterial hypertension: insight into central and peripheral pathophysiological mechanisms.” S. Malenfant, M. Lebret, É. Breton-Gagnon,et al.Eur Respir Rev27
Understanding the pathogenesis of occupational coal and silica dust-associated lung disease27
“Phosphodiesterase 4B inhibition: a potential novel strategy for treating pulmonary fibrosis.” M. Kolb, B. Crestani and T.M. Maher.Eur Respir Rev2023; 32: 220206.27
“Design of pulmonary rehabilitation programmes during acute exacerbations of COPD: a systematic review and network meta-analysis.” Ana Machado, Pedro Matos Silva, Vera Afreixo, Cátia Caneiras, Chris B27
Phosphodiesterase 4B inhibition: a potential novel strategy for treating pulmonary fibrosis26
Macrophages and the microbiome in chronic obstructive pulmonary disease26
Sarcoidosis-associated pulmonary fibrosis: joining the dots26
Targeting interleukin-33 and thymic stromal lymphopoietin pathways for novel pulmonary therapeutics in asthma and COPD26
Digital remote maintenance inhaler adherence interventions in COPD: a systematic review and meta-analysis26
Incidental discovery of interstitial lung disease: diagnostic approach, surveillance and perspectives25
Silicotuberculosis: a critical narrative review25
Impact of climate change on paediatric respiratory health: pollutants and aeroallergens24
Exertional ventilation/carbon dioxide output relationship in COPD: from physiological mechanisms to clinical applications24
Global respiratory health priorities at the beginning of the 21st century24
Natural variability in the disease course of SSc-ILD: implications for treatment24
Severe community-acquired pneumonia23
Social determinants of advanced chronic respiratory interventions: a scoping review23
Cardiac consequences of intermittent hypoxia: a matter of dose? A systematic review and meta-analysis in rodents23
Update on molecular pathology and role of liquid biopsy in nonsmall cell lung cancer23
Clinical–radiological–pathological correlation in pulmonary hypertension with unclear and/or multifactorial mechanisms22
Quality of life in patients with chronic respiratory failure on home mechanical ventilation22
Bronchiectasis in Asia: a review of current status and challenges21
Post-COVID-19 dyspnoea and pulmonary imaging: a systematic review and meta-analysis21
Impairment of hypoxic pulmonary vasoconstriction in acute respiratory distress syndrome21
Correction to subglottic secretion drainage for preventing ventilator-associated pneumonia: an overview of systematic reviews and an updated meta-analysis21
Holy Grail: the journey towards disease modification in asthma21
Lung cancer occurrence after an episode of tuberculosis: a systematic review and meta-analysis21
Antineutrophil cytoplasmic antibody-associated interstitial lung disease: a review21
Extracellular vesicle-mediated cellular crosstalk in lung repair, remodelling and regeneration21
The impact of therapeutics on mortality in hospitalised patients with COVID-19: systematic review and meta-analyses informing the European Respiratory Society living guideline20
Pulmonary veno-occlusive disease: illustrative cases and literature review20
Epidemiology of severe asthma in children: a systematic review and meta-analysis20
The association between alcohol consumption and pulmonary function: a scoping review20
No smoke without fire: the impact of cigarette smoking on the immune control of tuberculosis20
A scoping review on the risk of tuberculosis in specific population groups: can we expand the World Health Organization recommendations?20
20 years of neuromuscular electrical stimulation in COPD20
Common single nucleotide polymorphisms associated with idiopathic pulmonary fibrosis: a systematic review20
Obesity, leptin and host defence ofStreptococcus pneumoniae: the case for more human research20
Impact of ageing and pregnancy on the minute ventilation/carbon dioxide production response to exercise19
Developments in radiation techniques for thoracic malignancies19
Management of asthma exacerbations in the paediatric population: a systematic review19
The impact of outdoor air pollution on COVID-19: a review of evidence fromin vitro, animal, and human studies19
Fixed-intensity exercise tests to measure exertional dyspnoea in chronic heart and lung populations: a systematic review19
Role of autophagy in lung diseases and ageing19
Inhaled corticosteroids for the treatment of COVID-1918
Lung cancer is also a hereditary disease18
The nitric oxide–soluble guanylate cyclase–cGMP pathway in pulmonary hypertension: from PDE5 to soluble guanylate cyclase18
Predictors of sleep disordered breathing in children with Down syndrome: a systematic review and meta-analysis18
Barriers to and facilitators of populational adherence to prevention and control measures of COVID-19 and other respiratory infectious diseases: a qualitative evidence synthesis18
Human pluripotent stem cells for the modelling and treatment of respiratory diseases18
The cystic fibrosis lung microenvironment alters antibiotic activity: causes and effects18
0.11426997184753